Vaccitech plc
VACC · NASDAQ
12/31/2024 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $14,969 | $44,703 | $268 | $4,820 |
| % Growth | -66.5% | 16,580.2% | -94.4% | – |
| Cost of Goods Sold | $0 | $42,350 | $20,371 | $14,387 |
| Gross Profit | $0 | $2,353 | -$20,103 | -$9,567 |
| % Margin | 0% | 5.3% | -7,501.1% | -198.5% |
| R&D Expenses | $42,236 | $41,110 | $16,370 | $11,108 |
| G&A Expenses | $29,670 | $6,394 | $25,118 | $10,481 |
| SG&A Expenses | $29,670 | $6,394 | $25,118 | $10,481 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $12,209 | $567 | $332 | $42 |
| Operating Expenses | $84,115 | $47,504 | $41,488 | $21,588 |
| Operating Income | $1,176 | -$3,454 | -$45,221 | -$20,047 |
| % Margin | 7.9% | -7.7% | -16,873.5% | -415.9% |
| Other Income/Exp. Net | -$62,403 | $4,891 | -$5,919 | $2,208 |
| Pre-Tax Income | -$61,227 | $850 | -$51,140 | -$17,839 |
| Tax Expense | -$153 | -$4,471 | -$28 | $95 |
| Net Income | -$61,074 | $5,342 | -$51,112 | -$17,934 |
| % Margin | -408% | 11.9% | -19,071.6% | -372% |
| EPS | -1.55 | 0.14 | -1.97 | -2.27 |
| % Growth | -1,207.1% | 107.1% | 13.2% | – |
| EPS Diluted | -1.55 | 0.14 | -1.97 | -2.27 |
| Weighted Avg Shares Out | 39,348 | 37,248 | 25,894 | 7,905 |
| Weighted Avg Shares Out Dil | 39,348 | 38,169 | 25,894 | 7,905 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2,678 | $3,103 | $2 | $0 |
| Interest Expense | -$53 | $19 | $2,668 | $3,600 |
| Depreciation & Amortization | $0 | $4,323 | $4,335 | $3,529 |
| EBITDA | $1,176 | $5,192 | -$45,221 | -$16,518 |
| % Margin | 7.9% | 11.6% | -16,873.5% | -342.7% |